CINECA IRIS Institutional Research Information System

GADDUCCI, ANGIOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 39.463
AS - Asia 28.163
EU - Europa 22.343
SA - Sud America 3.159
AF - Africa 488
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 15
Totale 93.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.748
CN - Cina 9.674
IT - Italia 9.433
SG - Singapore 8.133
HK - Hong Kong 4.515
SE - Svezia 2.871
BR - Brasile 2.700
KR - Corea 2.303
UA - Ucraina 1.990
BG - Bulgaria 1.978
CA - Canada 1.482
DE - Germania 1.286
GB - Regno Unito 1.114
TR - Turchia 1.112
VN - Vietnam 1.067
CH - Svizzera 890
RU - Federazione Russa 868
FI - Finlandia 762
FR - Francia 450
IN - India 318
AR - Argentina 173
BD - Bangladesh 167
JP - Giappone 145
NL - Olanda 121
IQ - Iraq 111
MX - Messico 99
ZA - Sudafrica 89
BE - Belgio 88
ES - Italia 86
ID - Indonesia 78
SA - Arabia Saudita 77
PK - Pakistan 74
AT - Austria 69
CI - Costa d'Avorio 61
VE - Venezuela 61
EC - Ecuador 60
MA - Marocco 57
UZ - Uzbekistan 57
PL - Polonia 56
CO - Colombia 50
SN - Senegal 46
NG - Nigeria 42
CZ - Repubblica Ceca 39
IE - Irlanda 37
KE - Kenya 37
BJ - Benin 35
EG - Egitto 33
RO - Romania 33
JO - Giordania 31
PY - Paraguay 29
AE - Emirati Arabi Uniti 28
PH - Filippine 27
IL - Israele 26
TT - Trinidad e Tobago 26
AU - Australia 25
PT - Portogallo 25
JM - Giamaica 24
CL - Cile 22
BO - Bolivia 21
GR - Grecia 21
HU - Ungheria 21
NP - Nepal 21
TN - Tunisia 21
UY - Uruguay 21
MY - Malesia 18
CR - Costa Rica 17
PE - Perù 17
TW - Taiwan 17
OM - Oman 16
AZ - Azerbaigian 15
EE - Estonia 15
IR - Iran 15
LT - Lituania 15
LB - Libano 14
KG - Kirghizistan 13
KZ - Kazakistan 13
RS - Serbia 13
AL - Albania 12
DO - Repubblica Dominicana 12
DZ - Algeria 12
HN - Honduras 12
ET - Etiopia 11
DK - Danimarca 10
EU - Europa 10
TH - Thailandia 9
GT - Guatemala 8
HR - Croazia 8
KW - Kuwait 8
QA - Qatar 8
PA - Panama 7
AO - Angola 6
BH - Bahrain 6
CY - Cipro 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
BB - Barbados 5
LK - Sri Lanka 5
LY - Libia 5
AM - Armenia 4
BS - Bahamas 4
Totale 93.542
Salva come PNG Salva come JPEG
Città #
Hong Kong 4.486
Singapore 4.352
Ashburn 4.068
Milan 3.777
Chandler 3.225
Hefei 3.190
Jacksonville 2.700
Woodbridge 2.682
Ann Arbor 2.524
Seoul 2.296
Fairfield 2.246
Dallas 2.142
Sofia 1.974
Houston 1.939
Shanghai 1.552
Ottawa 1.360
Beijing 1.300
New York 1.176
Santa Clara 1.023
Seattle 1.008
Wilmington 881
Boardman 865
Bern 845
Princeton 800
Lawrence 775
Nanjing 772
Cambridge 684
Izmir 632
Des Moines 616
Medford 593
Los Angeles 559
Dearborn 501
Jüchen 475
Rome 380
Istanbul 370
Buffalo 362
Dong Ket 330
Nanchang 265
Redwood City 225
Kunming 200
São Paulo 199
San Diego 170
Council Bluffs 159
Boulder 154
Ho Chi Minh City 153
Redondo Beach 152
Shenyang 133
Ogden 130
Changsha 114
Tianjin 112
Tokyo 111
Hebei 108
Munich 108
Florence 107
London 100
Frankfurt am Main 97
Jiaxing 91
San Jose 90
Brussels 85
Verona 84
Lancaster 81
Chicago 78
Norwalk 77
Orange 75
Hanoi 72
Serra 72
Rio de Janeiro 71
Düsseldorf 64
Guangzhou 63
The Dalles 62
Pune 61
Abidjan 60
Hangzhou 58
Belo Horizonte 57
Brasília 57
Columbus 57
Turin 57
Pisa 56
Tashkent 54
Vienna 52
Dhaka 50
Fuzhou 47
Dakar 45
Baghdad 44
Curitiba 44
Changchun 42
Falls Church 42
Jinan 42
Washington 42
Detroit 41
Porto Alegre 40
Bremen 37
Atlanta 36
Riyadh 36
Cotonou 35
Edinburgh 33
Montreal 33
Nairobi 33
Salvador 33
Grafing 32
Totale 64.678
Salva come PNG Salva come JPEG
Nome #
Chemioterapia con CTX,DDP,ADM nel carcinoma ovarico in stadio avanzato 1.850
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 904
Isterectomia radicale secondo Wertheim-Meigs e radioterapia transcutanea postoperatoria con alte energie nel trattamento del carcinoma cervicale negli stadi Ib-II FIGO 401
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 271
Alfa2-macroglobulina e dismetabolismo glicidico in gravidanza 252
Chemioterapia neoadiuvante con schema PVB nel carcinoma cervicale avanzato. 237
A comparison of several tumor markers in the diagnosis, monitoring and follow-up of patients with epithelial ovarian cancer 224
Endometrial stromal sarco¬ma: Analysis of treatment failures and survival 213
Il recettore solubile dell' interleuchina-2(sIL-2r) nel carcinoma ovarico 208
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 205
Combined use of CA125 and CA15-3 in patients with endometrial carcinoma. 204
Functional Interaction Between BRCA1 and DNA Repair in Yeast May Uncover a Role of RAD50, RAD51, MRE11A, and MSH6 Somatic Variants in Cancer Development. 204
D-dimer in gynecological cancer 203
Carboplatin, doxorubicin and cyclophosphamide versus cisplatin, doxorubicin and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma. 202
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? 200
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 199
Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy. 196
Computed tomography in the follow-up of gynaecological neoplasias 195
Il dosaggio sierico del recettore solubile della interleuchina-2 nelle neoplasie ginecologiche 195
Computerized tomography (CT) semeiotics in the presurgical evaluation of gynaecological neoplasias. 194
Porphyrin-sensitized phototreatment as a conservative therapy in gynaecological oncology 194
Carcinoma developing in bladder exstrophy. Case report. 189
Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: An Italian multicenter retrospective study (CTF study) 189
Prospective multicenter study on CA 125 in postmenopausal pelvic masses. 188
Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer 188
La tomografia assiale computerizzata nel follow-up delle pazienti precedentemente trattate per neoplasie della cervice e del corpo uterino 187
Wertheim's radical hysterectomy with pelvic lymphadenectomy in the treatment of cervical carcinoma at the Obstetric and Gynecological Clinic of the University of Pisa 186
Follow-up strategies in gynecological oncology: searching appropriateness 186
Valutazione del CA125, TPA, GICA, CEA nella diagnosi e nel monitoraggio del carcinoma ovarico. 185
An analysis of approaches to the management of endome¬trial cancer in North America: A CTF study. 185
p53 nuclear accumulation in adenomatous hyperplasia and stage I endometrioid carcinoma. 184
Brenner's tumor 182
A comparison of the usefullness of serum measurements of CA125, CA50 and TATI in patients with malignant and benign gynecological pathology 182
Micro-RNAs and ovarian cancer: The state of art and perspectives of clinical research 180
Prothrombin fragment F 1+ 2 and thrombin- antithrombin III complex (TAT) plasma levels in patients with gynecological cancer 179
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest 179
The role of the French-Italian glossary of complications in the outcome evaluation of cervical cancer treatment: an Italian multicentric study 179
Novel targeted therapies in epithelial ovarian cancer: from basic research to the clinic 178
Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma 177
The therapy of verrucous carcinoma of the vulva. Observations on three cases. 176
Current management of fallopian tube carcinoma 175
Metabolismo glicidico ed emoglobina glicosilata (HbA1) in gravidanza 174
Prognostic role of immunosuppres¬sive acidic protein in advanced ovarian cancer. 174
First-line chemothe¬rapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients 174
Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: A debated clinical issue 174
Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study 173
Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature 172
Evaluation of the central dopaminergic activity in gestational hyperprolactinaemia by means of the electroretinographic technique 171
Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study) 171
Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature 170
Discontinuation of modern hormonal contraceptives: an Italian survey 170
Assenza di alterazioni dell'oncogene MDM-2 nel carcinoma ovarico 169
Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research 169
Aspetti colposcopici, citologici, e istologici dell'endometriosi cervicale. 168
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis 168
Adjuvant treatment of early stage ovarian carcinoma. 167
The role of computerized tomography of the pelvis in the presurgical staging of carcinoma of the cervix and of the ovary Eur.J. Gynaec. 166
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. 166
Weekly epirubicin in the treatment of gestational breast cancer (GBC) 166
Struma ovarii 165
Factor VIIIR: Ag plasma levels in patients with cervical and ovarian carcinoma 165
Fattori prognostici nei tumori misti mulleriani maligni (MMMT) dell' utero al I-II stadio: uno studio CTF 165
Serum solule interleukin-receptor (sIL-2R) assay in cervical an endometrial cancer. Preliminary data. 165
Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study 165
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. 165
Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer. 165
Iperprolattinemia e stati depressivi 163
Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer 163
Management of borderline ovarian tumors: Results of an Italian multicenter study 163
Analysis of failures in patients with stage I ovarian cancer: an Italian multicenter study 162
The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients 161
Adjuvant treatment of stage I-II malignant mixed mesodermal tumors (MMMT) of the uterus: a multicenter CTF study 161
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 161
Le complicanze postoperatorie dell'intervento di laparoisterectomia radicale con linfadenectomia pelvica 160
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma. 160
A combination of CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI in the monitoring of ovarian carcinoma 160
A comparative evaluation of the ability of serum CA125, CA19-9, CA15-3, CA50, CA72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma 160
Surgery and radiotherapy in the treatment of early stage uterine sarcomas. 160
Epidoxorubicin (EPI-DX) and lonidamine (LND) in refractory or recurrent epithelial ovarian cancer (EOC) 160
Uterine leiomyosarcoma: Analysis of treatment failures and survival 160
Pregnancy-associated cancers: Frequency and temporal trends in Italy 160
Pharmacological treatment for uterine leiomyosarcomas 159
Minimization of cisplatin nephrotoxicity in high-risk patients 158
Preoperative evaluation of D-Dimer and CA 125 levels in differentiating benign from malignant ovarian masses. 158
Prognostic factors in uterine sarcoma 158
Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS) 158
The topical administration of steroids in the treatment of typical vulvar dystrophy. 157
The evolving role of adjuvant therapy in endometrial cancer 157
Fertility drug use and risk of ovarian tumors: a debated clinical challenge 157
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 157
Verrucous carcinoma of the cervix 156
Iperespressione della proteina p53 nella iperplasia endometriale e nel carcinoma endonmetriale in I stadio 156
Surveillance of patients after initial treatment of ovarian cancer 156
Hemorrhagic uterine necrosis after surgical vessel ligation and B-Lynch suture in persistent post-cesarean uterine atony: case report and review of literature 156
Carcinosarcoma of the uterus : a clinicopathological multicenter CTF study 155
Porfirine e luce visibile nella diagnosi e nella terapia delle neoplasie. Prime esperienze cliniche in oncologia ginecologica. 154
CAM26, CAM29, and mucin- like associated antigen in epithelial ovarian cancer. 154
Sistema immunitario e carcinoma ovarico 153
The role of staging and adjuvant chemotherapy in stage I Malignant ovarian germ cell tumors (MOGTs): the MITO-9 study. 153
P53 overexpression in ovarian cancer: correlation with clinicopathological parameters and chemosensitivity 152
Totale 20.200
Salva come PNG Salva come JPEG
Categoria #
all - tutte 253.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 253.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.513 0 0 0 0 0 265 826 449 384 458 277 854
2021/20227.668 194 545 307 678 1.516 1.000 189 360 281 148 344 2.106
2022/20238.048 1.124 683 424 699 1.172 1.282 115 727 1.124 58 531 109
2023/202410.127 1.958 1.282 1.654 828 1.404 1.301 266 302 169 121 135 707
2024/202521.707 149 1.021 226 1.116 958 1.255 1.727 1.287 2.161 2.959 3.334 5.514
2025/202615.583 1.864 4.439 3.375 1.856 1.681 2.368 0 0 0 0 0 0
Totale 94.222